Dow Up0.07% Nasdaq Up0.61%

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM
4.25 Up 0.02(0.47%) Nov 26, 4:00PM EST
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.22-0.27-0.90-0.97
No. of Analysts2.001.002.002.00
Low Estimate-0.27-0.27-1.03-1.04
High Estimate-0.17-0.27-0.77-0.89
Year Ago EPS-0.15-0.25-1.30-0.90
Revenue EstCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Avg. EstimateNaNNaNNaNNaN
No. of Analysts1111
Low EstimateNaNNaNNaNNaN
High EstimateNaNNaNNaNNaN
Year Ago SalesNaNNaNNaNNaN
Sales Growth (year/est)N/AN/AN/AN/A
Earnings HistoryDec 13Mar 14Jun 14Sep 14
EPS Est-0.18-0.20-0.21-0.27
EPS Actual-0.15-0.25-0.17-0.17
Difference0.03-0.050.040.10
Surprise %16.70%-25.00%19.00%37.00%
EPS TrendsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.22-0.27-0.90-0.97
7 Days Ago-0.22-0.27-0.90-0.97
30 Days Ago-0.22-0.27-1.03-1.02
60 Days Ago-0.22-0.27-1.03-1.02
90 Days Ago-0.22-0.27-1.03-1.02
EPS RevisionsCurrent Qtr.
Dec 14
Next Qtr.
Mar 15
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0010
Up Last 30 Days0011
Down Last 30 Days1000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstGALTIndustrySectorS&P 500
Current Qtr.-46.70%N/A-72.80%18.80%
Next Qtr.-8.00%N/A-36.60%19.00%
This Year30.80%N/A30.80%8.00%
Next Year-7.80%N/A21.70%10.60%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A14.39%14.45%9.81%
Price/Earnings (avg. for comparison categories)-4.83-11.054.6521.09
PEG Ratio (avg. for comparison categories)N/A10.643.663.23
Currency in USD.